Literature DB >> 25269630

Incidental prostate cancer prevalence at radical cystoprostatectomy--importance of the histopathological work-up.

C Wetterauer1, M Weibel, J R Gsponer, T Vlajnic, T Zellweger, S Bütikofer, G Müller, H Püschel, A Bachmann, T C Gasser, L Bubendorf, C A Rentsch.   

Abstract

The reported incidental prostate cancer prevalence rates at radical cystoprostatectomy cover a range from 4 to 60 %. We investigated the influence of the histopathological work-up on prostate cancer prevalence rates. We identified 114 patients who had undergone cystoprostatectomy for bladder cancer between 2000 and 2012. Complete histopathological assessment was defined as follows: (i) complete embedding of the prostate gland, (ii) sectioning of 15 or more prostate sections, and (iii) processing as whole mount slides. Prostate cancer prevalence rates derived from complete and incomplete histopathological assessments were compared. The overall prostate cancer prevalence rate was 59.6 %. A mean of 14.4 macroscopic tissue sections (thickness 3-5 mm) were sectioned. Sectioning ≥15 sections resulted in a prostate cancer detection rate of 75 %, compared to 42.6 % when sectioning <15 sections (p < 0.001). Complete embedding yielded a prostate cancer detection rate of 72.3 and of 23.1 % for partly embedded prostates (p < 0.0001). Prostate cancer was detected in 68.8 % of the whole mounted samples and in 38.2 % of the samples sectioned as standard slides (p < 0.01); according to the criteria described by Epstein and Ohori, 44.1 % of the detected prostate cancers were clinically significant. The quality of the histopathological work-up significantly influences prostate cancer detection rates and might at least partially explain the highly variable reported incidental prostate cancer prevalence rates at cystoprostatectomy (CP). The high proportion of significant prostate cancer found in our series calls for a careful surgical approach to the prostate during CP.

Entities:  

Mesh:

Year:  2014        PMID: 25269630     DOI: 10.1007/s00428-014-1656-9

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  27 in total

1.  The incidence and relevance of prostate cancer in radical cystoprostatectomy specimens.

Authors:  M Alsinnawi; B Loftus; R Flynn; T McDermott; R Grainger; J A Thornhill
Journal:  Int Urol Nephrol       Date:  2012-07-07       Impact factor: 2.370

Review 2.  Critical evaluation of the prostate from cystoprostatectomies for bladder cancer: insights from a complete sampling with the whole mount technique.

Authors:  Rodolfo Montironi; Liang Cheng; Roberta Mazzucchelli; Marina Scarpelli; Ziya Kirkali; Francesco Montorsi; Antonio Lopez-Beltran
Journal:  Eur Urol       Date:  2008-10-28       Impact factor: 20.096

3.  Clinicopathological characteristics of incidental prostate cancer discovered from radical cystoprostatectomy specimen: a multicenter French study.

Authors:  Géraldine Pignot; Laurent Salomon; Yann Neuzillet; Alexandra Masson-Lecomte; Cédric Lebacle; Jean-Jacques Patard; Pierre Lunardi; Pascal Rischmann; Gilles Pasticier; Jean-Christophe Bernhard; Jérémy Cohen; Marc-Olivier Timsit; Virginie Verkarre; Benoit Peyronnet; Gregory Verhoest; Constance Le Goux; Marc Zerbib; François Brecheteau; Pierre Bigot; Stéphane Larre; Thibault Murez; Rodolphe Thuret; Emeric Lacarriere; Cécile Champy; Morgan Roupret; Eva Comperat; Julien Berger; Aurélien Descazeaud; Harry Toledano; Cyrille Bastide; Sébastien Lavilledieu; Christophe Avances; Francky Delage; Antoine Valeri; Benoit Molimard; Alain Houlgatte; Pascal Gres; Alain Donnaint; François Kleinclauss; Sophie Legal; Arnaud Doerfler; Nicolas Koutlidis; Luc Cormier; Jean-François Hetet; Philippe Colls; Alexis Arvin-Berod; Jean-Jacques Rambeaud; Hervé Quintens; Michel Soulie; Christian Pfister
Journal:  Ann Surg Oncol       Date:  2013-10-30       Impact factor: 5.344

4.  Urothelial and incidental prostate carcinoma in prostates from cystoprostatectomies for bladder cancer: is there a relationship between urothelial and prostate cancer?

Authors:  Francesca Barbisan; Roberta Mazzucchelli; Marina Scarpelli; Antonio Lopez-Beltran; Liang Cheng; Ziya Kirkali; Rodolfo Montironi
Journal:  BJU Int       Date:  2008-12-08       Impact factor: 5.588

5.  Is incidentally detected prostate cancer in patients undergoing radical cystoprostatectomy clinically significant?

Authors:  Roberta Mazzucchelli; Francesca Barbisan; Marina Scarpelli; Antonio Lopez-Beltran; Theodorus H van der Kwast; Liang Cheng; Rodolfo Montironi
Journal:  Am J Clin Pathol       Date:  2009-02       Impact factor: 2.493

6.  Overall clinical outcomes after nerve and seminal sparing radical cystectomy for the treatment of organ confined bladder cancer.

Authors:  Renzo Colombo; Roberto Bertini; Andrea Salonia; Richard Naspro; Massimo Ghezzi; Bruno Mazzoccoli; Federico Deho'; Francesco Montorsi; Patrizio Rigatti
Journal:  J Urol       Date:  2004-05       Impact factor: 7.450

7.  Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.

Authors:  J Ferlay; E Steliarova-Foucher; J Lortet-Tieulent; S Rosso; J W W Coebergh; H Comber; D Forman; F Bray
Journal:  Eur J Cancer       Date:  2013-02-26       Impact factor: 9.162

8.  Cancer identified incidentally in the prostate following radical cystoprostatectomy: an Australian study.

Authors:  Nariman Ahmadi; Warick J Delprado; Andrew J Brooks; Phillip C Brenner; Graham M Coombes; Alexander Grant; Manish I Patel
Journal:  ANZ J Surg       Date:  2012-12-10       Impact factor: 1.872

9.  Higher than expected association of clinical prostate and bladder cancers.

Authors:  Amar Singh; Yoshihisa Kinoshita; Peter M Rovito; Steve Landas; Jon Silberstein; Imad Nsouli; Ching Y Wang; Gabriel P Haas
Journal:  J Urol       Date:  2008-05       Impact factor: 7.450

10.  Incidentally found prostate cancer and influence on overall survival after radical cystoprostatectomy.

Authors:  Algimantas Sruogis; Albertas Ulys; Giedre Smailyte; Zygimantas Kardelis; Arunas Kulboka; Giedre Anglickienė; Nerimantas Samalavicius; Marius Anglickis
Journal:  Prostate Cancer       Date:  2012-06-03
View more
  2 in total

Review 1.  Concomitant bladder cancer and prostate cancer: challenges and controversies.

Authors:  Antonio Lopez-Beltran; Liang Cheng; Francesco Montorsi; Maria Scarpelli; Maria R Raspollini; Rodolfo Montironi
Journal:  Nat Rev Urol       Date:  2017-08-16       Impact factor: 14.432

2.  Concomitant Gleason Score ≥ 7 prostate cancer is an independent prognosticator for poor survival in nonmetastatic bladder cancer patients undergoing radical cystoprostatectomy.

Authors:  Christian Thomas; Alexander Giesswein; Michael Hainz; Raimund Stein; Peter Rubenwolf; Frederik C Roos; Andreas Neisius; Sebastian Nestler; Christian Hampel; Wolfgang Jäger; Christoph Wiesner; Joachim W Thüroff
Journal:  Int Urol Nephrol       Date:  2015-09-16       Impact factor: 2.370

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.